Clinical Trial Update: Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating safety and efficacy of umbilical cord blood regulatory T cells combined with liraglutide for autoimmune diabetes and type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diabetes
• Type 1 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)
• umbilical cord blood regulatory T cells (regulatory T cells derived from umbilical cord blood)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Type1 Diabetes Mellitus, Autoimmune Diabetes | Phase 1, Phase 2 | Status: UNKNOWN